Crinetics Pharmaceuticals (CRNX) Free Cash Flow (2017 - 2026)

Crinetics Pharmaceuticals' quarterly Free Cash Flow came in at -$125.2 million in Q1 2026, down 41.09% year-on-year from -$212.5 million in Q1 2025, and down 26.94% quarter-over-quarter from -$98.6 million in Q4 2025.

Crinetics Pharmaceuticals has reported Free Cash Flow for 10 years, with the latest figure at -$125.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Free Cash Flow fell 41.09% year-over-year to -$125.2 million; the trailing twelve-month figure through Mar 2026 stood at -$420.1 million (down 55.76% YoY), and the FY2025 full-year result was -$383.7 million, down 63.94% from the prior year.
  • Free Cash Flow for Q1 2026 stood at -$125.2 million, down from -$98.6 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$13.6 million in Q1 2022, with the low at -$125.2 million in Q1 2026.
  • Average Free Cash Flow over 5 years is -$60.5 million, with a median of -$49.8 million recorded in 2024.
  • Year-over-year, Free Cash Flow jumped 32.15% in 2022 and plunged 198.86% in 2023.
  • Tracing CRNX's Free Cash Flow over 5 years: stood at -$36.8 million in 2022, then fell by 3.05% to -$37.9 million in 2023, then slumped by 79.04% to -$67.9 million in 2024, then tumbled by 45.22% to -$98.6 million in 2025, then fell by 26.94% to -$125.2 million in 2026.
  • The last three Free Cash Flow figures came in at -$125.2 million (Q1 2026), -$98.6 million (Q4 2025), and -$106.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.67 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.29 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 848.30 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67 Mn
10 Crinetics Pharmaceuticals 3.59 Bn 3.59 Bn 10.53 Mn -125.17 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -125.17 Mn
Mar 31, 2026 -125.17 Mn
Dec 31, 2025 -98.61 Mn
Dec 31, 2025 -98.61 Mn
Sep 30, 2025 -106.33 Mn
Sep 30, 2025 -106.33 Mn
Jun 30, 2025 -90.03 Mn
Jun 30, 2025 -90.03 Mn
Mar 31, 2025 -88.72 Mn
Mar 31, 2025 -88.72 Mn
Dec 31, 2024 -67.90 Mn
Dec 31, 2024 -67.90 Mn
Sep 30, 2024 -63.35 Mn
Sep 30, 2024 -63.35 Mn
Jun 30, 2024 -49.76 Mn
Jun 30, 2024 -49.76 Mn
Mar 31, 2024 -53.02 Mn
Mar 31, 2024 -53.02 Mn
Dec 31, 2023 -37.93 Mn
Dec 31, 2023 -37.93 Mn
Sep 30, 2023 -44.84 Mn
Sep 30, 2023 -44.84 Mn
Jun 30, 2023 -45.97 Mn
Jun 30, 2023 -45.97 Mn
Mar 31, 2023 -40.73 Mn
Mar 31, 2023 -40.73 Mn
Dec 31, 2022 -36.80 Mn
Dec 31, 2022 -36.80 Mn
Sep 30, 2022 -37.84 Mn
Sep 30, 2022 -37.84 Mn
Jun 30, 2022 -28.59 Mn
Jun 30, 2022 -28.59 Mn
Mar 31, 2022 -13.63 Mn
Mar 31, 2022 -13.63 Mn
Dec 31, 2021 -22.92 Mn
Dec 31, 2021 -22.92 Mn
Sep 30, 2021 -26.09 Mn
Sep 30, 2021 -26.09 Mn
Jun 30, 2021 -19.93 Mn
Jun 30, 2021 -19.93 Mn
Mar 31, 2021 -20.09 Mn
Mar 31, 2021 -20.09 Mn
Dec 31, 2020 -15.96 Mn
Dec 31, 2020 -15.96 Mn
Sep 30, 2020 -18.10 Mn
Sep 30, 2020 -18.10 Mn
Jun 30, 2020 -15.87 Mn
Jun 30, 2020 -15.87 Mn
Mar 31, 2020 -12.29 Mn
Mar 31, 2020 -12.29 Mn
Dec 31, 2019 -13.10 Mn
Dec 31, 2019 -13.10 Mn
Sep 30, 2019 -13.61 Mn
Sep 30, 2019 -13.61 Mn
Jun 30, 2019 -12.62 Mn
Jun 30, 2019 -12.62 Mn
Mar 31, 2019 -7.17 Mn
Mar 31, 2019 -7.17 Mn
Dec 31, 2018 -6.92 Mn
Dec 31, 2018 -6.92 Mn
Sep 30, 2018 -5.79 Mn
Sep 30, 2018 -5.79 Mn
Jun 30, 2018 -4.34 Mn
Jun 30, 2018 -4.34 Mn
Mar 31, 2018 -3.47 Mn
Mar 31, 2018 -3.47 Mn
Dec 31, 2017 -2.74 Mn
Dec 31, 2017 -2.74 Mn
Sep 30, 2017 -2.46 Mn
Sep 30, 2017 -2.46 Mn